Skip to Content
Merck
CN

Tenoxicam-associated hepatic injury: a case report and review.

European journal of gastroenterology & hepatology (1997-04-01)
P Katsinelos, I Katsos, K Patsiaoura, P Xiarchos, I Goulis, N Eugenidis
ABSTRACT

A 51-year-old woman developed jaundice while taking tenoxicam. A full evaluation, including ultrasound, computed tomography, endoscopic cholangiography and liver biopsy, confirmed the diagnosis of mixed hepatic injury. The patient's jaundice and all other liver function abnormalities normalized 1 month after she discontinued taking tenoxicam. This is the first case report of mixed hepatic injury, confirmed with biopsy, associated with tenoxicam. Tenoxicam should be considered as a potential cause of hepatic injury when other more common aetiologies have been excluded.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tenoxicam, NSAID
Tenoxicam, European Pharmacopoeia (EP) Reference Standard